Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cielo vs Queen RX

Cielo
Graded #121

Higher grade

vs+3.1000000000000085
Queen RX
Graded #192

Lower grade

The verdict

Cielo takes it — 69.4/100 to 66.3/100.

Cielo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons — a focused, single-purpose alternative to…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +1
76
77
Dose & formulationCielo +28
85
57
Clinical oversightCielo +10
79
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +8
67
75
Contract termsQueen RX +41
20
61
Cielo · left barQueen RX · right bar

The numbers

MetricCieloQueen RX
WeighScore69.4/10066.3/100
GradeCC
Scorecard rank#121#192
Semaglutide$149/mo (all doses, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$249/mo (all doses, compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Cielo

Graded #121 · C

Strengths

  • Among the lowest 3-month bundle prices in compounded GLP-1 ($115/mo semaglutide)
  • Single flat price across all doses simplifies titration planning
  • Corporate address (St. Petersburg, FL) and customer-service phone published

Where it loses points

  • No LegitScript, NABP .pharmacy, or HIPAA badge on the home page
  • Pharmacy partner not named (only 'regulated FDA pharmacy partners')
  • State coverage list not published — can't verify all-50-state availability
  • Clinical care runs through MD Integrations, a shared third-party network used by many brands
  • No brand-name Wegovy or Zepbound option
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard